Heart Transplant Cardiology Billing Services
A heart transplant patient doesn’t generate one claim they generate a claim history that stretches from pre-transplant evaluation, through the transplant surgery itself, into a lifetime of surveillance biopsies, immunosuppression management and rejection monitoring. In the first year alone, a single patient may undergo close to half a dozen endomyocardial biopsies, each one a separately reportable service that has to be coded correctly every single time. Billing for this population isn’t a one-time procedural claim it’s an ongoing relationship with the payer that spans years and it needs a billing team that understands the full arc of post-transplant care, not just the surgery date.
At Cardiology Billing Services, heart transplant billing is treated as its own continuum pre-transplant workup, the transplant procedure and the years of surveillance and immunosuppression management that follow rather than a single high-value claim that gets attention once and is then handled like routine cardiology billing afterward.
Why Heart Transplant Billing Is a Different Kind of Complex
Most cardiology billing revolves around a discrete encounter: a visit, a test, a procedure. Heart transplant billing revolves around a relationship that continues indefinitely and that changes the entire billing approach:
One surgical code covers a complex operation.
The transplant procedure itself is billed under a single code, 33945, regardless of surgical complexity which means everything that determines appropriate reimbursement has to be captured through accurate documentation of any additional services performed alongside it, not through the primary code itself.
Serial, recurring procedures dominate the first year.
Endomyocardial biopsies are performed repeatedly on a set surveillance schedule and each one is billed as its own encounter meaning coding accuracy has to hold up consistently across dozens of claims per patient, not just once.
Bundling rules are actively scrutinized.
Federal oversight bodies have specifically flagged the pairing of right heart catheterization and endomyocardial biopsy in the same session, since the two are bundled under most circumstances unless a genuinely distinct clinical reason justifies billing both.
Transplant status itself is a coding category.
ICD-10-CM Z94.1 (heart transplant status) has to appear consistently across a patient's record and it interacts directly with how rejection, complications and comorbidities are coded going forward.
Immunosuppression management is a permanent fixture of care.
Medication monitoring, drug-level testing and the visits built around adjusting a lifelong immunosuppressive regimen are a recurring billing category with their own documentation expectations.
Medical Coding Services
This is exactly where our Medical Coding Services team focuses close attention the difference between a heart transplant billing relationship that stays clean for years and one that accumulates avoidable denials usually comes down to whether this recurring structure is understood from day one.
Pre-Transplant Evaluation and Listing
Before transplantation, patients typically undergo an extensive evaluation hemodynamic assessment, imaging and often mechanical circulatory support as a bridge to transplant. Billing at this stage includes:
- Comprehensive diagnostic workups tied to advanced heart failure staging, coordinated closely with our Heart Failure Cardiology Billing Services team, since most transplant candidates are already being managed under a heart failure protocol before listing
- Ventricular assist device (VAD) implantation as a bridge-to-transplant strategy, using the appropriate implantation codes distinct from the eventual transplant procedure itself
- UNOS listing-related documentation, which has to clearly support medical necessity for transplant candidacy in the chart, since payers frequently request this documentation separately from the procedural claim
Financial Clearance and Single-Case Agreements
Transplant billing carries a step that most cardiology billing never encounters: financial clearance well before the surgical date. Because standard fee schedules rarely align with the true cost of a transplant episode, many transplant programs negotiate a single-case agreement (SCA) with the patient's payer ahead of time, establishing a specific reimbursement arrangement for that individual case rather than relying on default contracted rates. Getting this step right matters as much as any procedural code that follows a transplant performed without confirmed financial clearance or an executed single-case agreement can leave a program exposed to significant underpayment on one of the highest-cost episodes in cardiology. We coordinate this financial clearance process alongside the clinical documentation, so the case is contractually protected before it ever reaches the operating room.
Transplant Surgery Coding
The Transplant Procedure
33945 heart transplant, with or without recipient cardiectomy is the single code that covers the transplant operation itself. Because this code doesn't vary by complexity, correct reimbursement depends heavily on capturing every additional, separately reportable service performed during the same hospitalization.
VAD Removal at the Time of Transplant
When a patient arrives at transplant with an existing ventricular assist device, its removal is coded separately from the transplant itself:
- 33980 removal of an implantable, single-ventricle VAD
- 33990–33993 insertion, removal, or repositioning of a percutaneous VAD, depending on the specific approach and access used
Getting the sequencing right between VAD removal codes and the transplant code is one of the more common documentation gaps we see when practices switch to us the operative note has to make clear these were distinct components of the same surgical encounter, not implied by proximity alone.
Artificial Heart and Component Devices
Where a total artificial heart or supporting components are used as part of the surgical pathway, these are billed under their own separate code family rather than folded into the transplant code and require documentation specific to the device used.
Re-Transplantation
When a transplanted heart fails and a patient requires a second transplant, the procedure is coded and documented distinctly from a primary transplant, with the operative note needing to clearly establish that this is a re-transplantation rather than an initial procedure. This distinction affects both the surgical claim and the diagnosis coding that follows, since the clinical history of graft failure has to be reflected accurately alongside the new transplant status.
Multi-Organ Transplants
Some patients require a combined transplant most often heart-lung or heart-kidney performed in a single surgical episode. These cases are billed with each organ's transplant procedure reported and documented separately, since combined-organ transplants carry their own coordination requirements between surgical teams and, frequently, their own payer authorization process distinct from an isolated heart transplant.
Post-Transplant Surveillance and Rejection Monitoring
Endomyocardial Biopsy (EMB)
93505 is the code for endomyocardial biopsy, the gold-standard method for detecting transplant rejection. Transplant recipients typically undergo several biopsies during the first year following a defined surveillance schedule and each biopsy is billed as its own unit of service regardless of how many tissue samples are taken during that single procedure.
The Right Heart Catheterization Bundling Issue
Endomyocardial biopsy is frequently performed alongside right heart catheterization and federal oversight has specifically scrutinized this pairing. Under most circumstances, the two are bundled together and only one is separately billable the exception is when there's a genuinely distinct clinical reason to perform both, such as a transplant surveillance biopsy combined with a workup for a separate condition like pulmonary hypertension. We document this distinction clearly before billing both services, rather than defaulting to billing them together and risking a compliance flag.
Rejection Grading and Complication Coding
Biopsy results are graded using the International Society for Heart and Lung Transplantation (ISHLT) rejection classification and that grade has to translate accurately into diagnosis coding ranging from no evidence of rejection to active cellular or antibody-mediated rejection under ICD-10-CM T86.2x, alongside the transplant status code Z94.1. Cardiac allograft vasculopathy (CAV), a leading long-term complication of heart transplantation, is coded and monitored separately through surveillance angiography and documentation has to distinguish CAV findings from native coronary artery disease.
Billing for Active Rejection Treatment
A confirmed rejection episode moves billing beyond monitoring and into active treatment, which carries its own coding requirements. Antibody-mediated rejection in particular is often treated with therapies such as plasmapheresis, intravenous immunoglobulin (IVIG), or rituximab, each billed under distinct codes tied to the specific therapy and, for infused or apheresis-based treatments, the documented duration or number of sessions. These treatment claims are coded separately from the biopsy or monitoring encounter that identified the rejection, since payers expect the diagnostic finding and the treatment response to each be independently supported in the record.
Emerging Non-Invasive Surveillance
Gene expression profiling of transplant biopsy tissue reported under code 0087U is an increasingly used molecular alternative or complement to biopsy-based surveillance in appropriately selected patients, reducing the frequency of invasive biopsies over time. As payer coverage policies continue to evolve around this technology, we track which patients and circumstances support its use as a covered service rather than assuming uniform coverage across all payers.
Immunosuppression Management and Long-Term Care Billing
Lifelong immunosuppressive therapy requires ongoing drug-level monitoring, medication adjustment visits and management of complications related to long-term immune suppression, such as infection risk and post-transplant lymphoproliferative disorder (PTLD) a malignancy specifically associated with long-term immunosuppression that requires its own diagnosis coding and, when treatment is required, coordination between transplant cardiology and oncology billing. Visits built around this ongoing management are coded using standard evaluation and management levels supported by the documented complexity of medication titration and monitoring not treated as routine follow-up visits regardless of how stable a patient appears.
Cardiac rehabilitation is also a common part of post-transplant recovery and we coordinate this phase of care with our Cardiac Rehabilitation Billing Services team so the transition from acute post-surgical care into structured recovery billing happens without a reimbursement gap.
Facility Billing and MS-DRG Coordination
Everything above covers professional, physician-side billing but for the hospital performing the transplant, the facility side runs on its own MS-DRG logic, with heart transplantation grouping into a specific, high-weighted DRG distinct from other cardiac surgery. Correct physician-side coding doesn't automatically mean the facility claim is aligned with it and the two need to be reconciled so the hospital's inpatient claim and the surgeon's professional claim reflect the same documented episode of care. This reconciliation matters even more on transplant cases than on most cardiac surgery, given how closely both government and commercial payers monitor reimbursement accuracy on transplant-specific DRGs.
Global Period and Telehealth Follow-Up
The transplant procedure carries a global surgical period during which routine post-operative visits are bundled into the surgical fee and distinguishing a bundled follow-up visit from a separately billable complication requires the same careful documentation review we apply across our surgical billing work. Once a patient moves into stable, longer-term follow-up, many transplant programs now offer telehealth visits for routine immunosuppression check-ins and medication management and these are coded with the correct place-of-service and modifier combination where payers permit it, extending the same approach we use across our other cardiology specialty billing.
Where Heart Transplant Claims Most Often Get Denied
Endomyocardial biopsy billed alongside right heart catheterization without documentation supporting a genuinely distinct clinical indication for both.
VAD removal codes missing or mismatched at the time of transplant, understating the complexity of the surgical encounter.
Transplant status (Z94.1) inconsistently documented, affecting how downstream rejection and complication claims are interpreted.
Rejection grading not translated correctly into diagnosis coding, leaving the claim without the specificity payers expect for active rejection management.
Immunosuppression management visits under-coded as routine follow-up rather than reflecting the actual medical decision-making involved in long-term regimen management.
Gene expression profiling billed without payer-specific coverage confirmation, given that coverage policy for this technology still varies.
Missing or unexecuted single-case agreements, resulting in the transplant episode defaulting to standard fee-schedule reimbursement rather than the negotiated case rate.
Physician and facility claims that don't align on a combined or re-transplant case, creating conflicting documentation during payer review.
Our Claims Submission & Tracking and Denial Management teams review claims against these exact failure points before submission, rather than discovering them after a denial arrives.
Our Revenue Cycle Approach for Heart Transplant Billing
Pre-transplant documentation review
Pre-transplant documentation review, confirming UNOS listing and medical necessity documentation is complete before evaluation-stage claims are submitted.
Surgical claim construction
Surgical claim construction, capturing the transplant procedure alongside every separately reportable component VAD removal, artificial heart components and any concurrent cardiac procedures.
Surveillance schedule tracking
Surveillance schedule tracking, so serial biopsy claims are billed accurately and consistently across the full first-year protocol and beyond.
Bundling compliance review
Bundling compliance review, specifically screening for the EMB/RHC pairing before submission.
Ongoing immunosuppression visit coding
Ongoing immunosuppression visit coding, matched to actual documented complexity rather than treated as routine.
Full revenue cycle visibility
Full revenue cycle visibility, tying every stage of transplant-related billing into our broader Revenue Cycle Management for Cardiology reporting, so your practice can see reimbursement performance across the entire transplant care continuum, not just the surgical claim.
Why This Requires Specialized Transplant Billing Expertise
Heart transplant billing rewards continuity and punishes shortcuts more than almost any other area of cardiology billing, simply because a single patient generates so many recurring, interrelated claims over time. Our coders track ISHLT rejection grading, transplant status documentation and the surveillance schedules that shape this specialty specifically, staying current on how CPT and ICD-10-CM codes evolve as new surveillance technologies like gene expression profiling gain broader payer acceptance. Every claim is handled under the same HIPAA-compliant, CMS-aligned process we apply across our full range of cardiology billing specialties, with the coordination across heart failure, cardiothoracic surgery and cardiac imaging billing that transplant care naturally requires.
Frequently Asked Questions
How is heart transplant billing different from other cardiac surgery billing?
It extends far beyond the surgical encounter itself into years of recurring surveillance biopsies, rejection monitoring and immunosuppression management each with its own coding and documentation requirements that most surgical billing doesn't need to account for.
Why are endomyocardial biopsy claims sometimes denied?
Most often because the biopsy was billed alongside a right heart catheterization without documentation supporting a distinct clinical reason for both, since the two are bundled together under most circumstances.
Do you code for VAD removal performed at the time of transplant?
Yes. VAD removal is billed separately from the transplant procedure itself, using the code specific to the type of device and removal approach involved.
How is transplant rejection coded?
Rejection identified on biopsy is graded using the ISHLT classification system and that grade is translated into the appropriate ICD-10-CM code alongside the patient's ongoing transplant status code.
Do you handle billing for newer non-invasive rejection surveillance methods like gene expression profiling?
Yes. We track payer-specific coverage policy for this technology, since coverage still varies and isn't yet uniformly accepted across all payers.
What is a single-case agreement and does it affect transplant billing?
A single-case agreement is a payer-specific reimbursement arrangement negotiated for an individual transplant case, since standard fee schedules rarely reflect the true cost of a transplant episode. We coordinate this financial clearance step before the surgical date so the case is contractually protected.
Do you bill for the treatment of a confirmed rejection episode, not just the biopsy that identifies it?
Yes. Treatments such as plasmapheresis, IVIG and rituximab for antibody-mediated rejection are billed under their own codes, separate from the diagnostic biopsy or monitoring encounter.
How is billing different if a patient needs a second heart transplant?
Re-transplantation is coded and documented distinctly from a primary transplant, with the operative note establishing the graft failure history alongside the new transplant status.
Do you handle billing for combined organ transplants, such as heart-lung or heart-kidney?
Yes. Each organ's transplant procedure is reported and documented separately, reflecting the distinct surgical and payer authorization requirements of a combined-organ case.
How does this connect to your other cardiology specialty services?
Heart transplant patients typically move through heart failure management before transplant, cardiothoracic surgery billing at the time of transplant and cardiac rehabilitation billing afterward our teams coordinate across all of these rather than treating each stage in isolation.
Protect the Revenue Across the Entire Transplant Journey
Heart transplant billing doesn't end when the surgery is billed it continues for years and every recurring surveillance claim is an opportunity for revenue to slip through the cracks if the coding isn't consistent. If your practice is dealing with denied biopsy claims, underpaid surgical encounters, or gaps in long-term transplant billing, we'll review your data and show you exactly where reimbursement is falling short. Reach out for a complimentary claims review.